Cyprus Ties NICE Kidney Guideline to Better CKD Care in First Year

Chronic kidney disease (CKD) affects millions worldwide and carries substantial morbidity, mortality, and healthcare costs, yet evidence-based recommendations for its management are implemented and monitored very unevenly across countries. Cyprus has historically reported among the highest incidences of kidney replacement therapy in Europe, but until recently it lacked clinical guidelines adapted to its local health system and had no structured framework for monitoring the quality of CKD care. A new study published in BMC Nephrology describes how researchers addressed both gaps by contextualizing the National Institute for Health and Care Excellence (NICE) guideline NG203 for the Cyprus General Health System (GeSY) and embedding guideline-based clinical quality indicators into the system’s routine information infrastructure.

The adaptation was not a simple translation of British recommendations. The team, led by Panayiotis Kouis and Georgios K. Nikolopoulos with a dedicated CKD Contextualization group, used a structured process that included a series of working meetings followed by public consultation. Through this process, they selected quality indicators judged relevant and feasible for the Cypriot context and integrated them into the GeSY information system, allowing care quality to be measured continuously rather than through one-off audits. The evaluation then compared indicator outputs between a baseline 12-month period before the contextualized guideline was introduced (1 November 2023 to 31 October 2024) and a post-introduction 12-month reporting period (1 November 2024 to 31 October 2025).

Six indicators were evaluated across the two periods. Four of them improved after the guideline’s introduction, with statistically significant increases observed in annual urine albumin-to-creatinine ratio testing in people with CKD, renal function monitoring among chronic users of nonsteroidal anti-inflammatory drugs, confirmation of a CKD diagnosis using repeated estimated glomerular filtration rate (eGFR) testing, and combined eGFR and albuminuria assessment at the time of diagnosis.

The authors are careful about interpretation. The study reports changes in quality-of-care indicators during the first year of monitoring, and the introduction of the indicators was associated with these measurable improvements; the design cannot definitively prove causation, and the pharmacological findings show how much work remains. Even so, the conclusion offers a transferable lesson for health systems with limited prior experience in quality-of-care monitoring: structured adaptation of international guidance, combined with routine measurement built into everyday clinical information systems, may support real improvements in chronic disease care. The article is being shared early as a peer-reviewed, accepted, open-access version of record in progress, citable under its permanent DOI, and the findings arrive at a moment when other countries are grappling with the same question of how to turn international guidelines into locally owned, routinely measured practice.

Subject of Research: Implementation and one-year evaluation of contextualized NICE-based chronic kidney disease quality indicators in the Cyprus General Health System.

Article Title: Improving chronic kidney disease care through quality indicators monitoring: one year follow-up study after the introduction of a contextualized NICE guideline in Cyprus

Article References: Kouis, P., Mitsides, N., Sekkidou, M., Kyriacou, M., Sioftanos, A., Achilleos, H., Giallouros, G., Grime, C., Kolokotroni, O., Kousios, A., McGuire, H., Yiallourou, A., CKD Contextualization group, Charilaou, C., Demetriou, D., Elia, A., Hoplaros, C., Mavrokordatou, E., Mylonas, C., … Nikolopoulos, G. K. (2026). Improving chronic kidney disease care through quality indicators monitoring: one year follow-up study after the introduction of a contextualized NICE guideline in Cyprus. BMC Nephrology. https://doi.org/10.1186/s12882-026-05457-0

Image Credits: AI Generated

DOI: 10.1186/s12882-026-05457-0

Keywords: chronic kidney disease, quality indicators, NICE guideline, Cyprus, health system implementation, eGFR, albuminuria testing, kidney replacement therapy, clinical guideline adaptation, quality of care monitoring, Improving, chronic